Goserelin Acetate Extended-Release Implant is mainly used for the treatment of metastatic prostate cancer, and its price is related to the drug specifications and other factors, about 1,700 yuan to 4,000 yuan per unit. Goserelin is a synthetic analog of natural gonadotropin-releasing hormone (LHRH), and its long-term use can inhibit the secretion of pituitary gonadotropins, which causes a decrease in serum testosterone in men and serum estradiol in women. Studies have shown that it can be an effective alternative to surgical debulking in metastatic prostate cancer. Clinical indications include: for hormone-treated prostate cancer; for hormone-treated breast cancer in premenopausal and perimenopausal women; for endometriosis, to relieve symptoms including pain and to reduce the size and number of endometrial lesions. The price of Goserelin Acetate Extended-Release Implant is affected by factors such as drug retailer, drug specification, and sales region, and its reference price is about $1,700 to $4,400 per unit. If prostate cancer is suspected or diagnosed, it is recommended to go to a regular hospital for comprehensive assessment of the condition and follow the doctor’s instructions to cooperate with the treatment, so as to avoid delaying the condition. Please strictly follow the doctor’s instructions for medication, and do not use medication on your own.